Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Benzene Exposure in Non-Hodgkin Lymphoma

Cancer Epidemiol; ePub 2016 Mar 2; Switchenko, Bulka, et al

Publish date:: March 23, 2016

Higher levels of passive benzene exposure are associated with increased risk for non-Hodgkin lymphoma (NHL) across various lag periods, according to a study of benzene releases and incident cases of NHL. Researchers found:

• A range of scaling factors and exposure periods were used to show that increased levels of passive benzene exposure were associated with higher risk of NHL.

• The best fitting model, with a scaling factor of 4 kilometers and exposure period from 1989 to 1993, showed that higher exposure levels were associated with increased NHL risk.

Citation: Switchenko JM, Bulka C, Ward K, et al. Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma. [Published online ahead of print March 2, 2016]. Cancer Epidemiol. doi:10.1016/j.canep.2016.01.008.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,